The hypoxia inducible factor/erythropoietin (EPO)/EPO receptor pathway is disturbed in a rat model of chronic kidney disease related anemiaDaniel Landau(Tel Aviv University), Yael Segev(Ben-Gurion University of the Negev)PLoS ONEMay 8, 201810.1371/journal.pone.0196684Cited by 41SaveCiteExport RISWatch citationsRelated PapersSystemic and renal growth hormone–IGF1 axis involvement in a mouse model of type 2 diabetes|Diabetologia|2007|20